Candidate imaging biomarkers for PMP22‐related inherited neuropathies
Abstract Objective Charcot–Marie–Tooth type 1A (CMT1A) and hereditary neuropathy with liability to pressure palsy (HNPP) are caused by mutations to the peripheral myelin protein 22 (PMP22) gene. A need exists for sensitive and reliable biomarkers of progression and treatment response. Magnetic reson...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Artikkeli |
| Kieli: | English |
| Julkaistu: |
Wiley
2022-07-01
|
| Sarja: | Annals of Clinical and Translational Neurology |
| Linkit: | https://doi.org/10.1002/acn3.51561 |